Astrana Health, Inc. · Healthcare · Medical Care Facilities
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$20.38
−$0.53 (−2.53%) 4:00 PM ET
After hours$20.73
+$0.35 (+1.72%) 7:29 AM ET
Prev closePrevC$20.91
OpenOpen$20.86
Day highHigh$21.63
Day lowLow$20.28
VolumeVol556,697
Avg volAvgVol533,910
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$1.02B
P/E ratio
101.90
FY Revenue
$2.90B
EPS
0.20
Gross Margin
9.29%
Sector
Healthcare
AI report sections
MIXED
ASTH
Astrana Health, Inc.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+41% (Above avg)
Vol/Avg: 1.41×
RSI
47.99(Neutral)
Neutral (40–60)
0255075100
MACD momentum
Intraday
+0.01 (Strong)
MACD: -0.02 Signal: -0.04
Short-Term
+0.25 (Strong)
MACD: -1.11 Signal: -1.35
Long-Term
-0.02 (Weak)
MACD: -1.57 Signal: -1.54
Intraday trend score
51.00
LOW41.00HIGH62.00
Latest news
ASTH•6 articles•Positive: 1Neutral: 0Negative: 0
PositiveBenzinga• Prnewswire
Astrana Health, Inc. Reports Second Quarter 2025 Results
Astrana Health reported strong Q2 2025 financial results with total revenue of $654.8 million, up 35% year-over-year, and completed its acquisition of Prospect Health, expanding its healthcare service platform.
Strong revenue growth of 35%, successful Prospect Health acquisition, positive CEO commentary about company's strategic positioning, and reiteration of full-year guidance indicate robust business performance
UnknownZacks Investment Research• Zacks Equity Research
Here is Why Growth Investors Should Buy Astrana Health, Inc. (ASTH) Now
Astrana Health, Inc. (ASTH) possesses solid growth attributes, which could help it handily outperform the market.
ASTH
UnknownZacks Investment Research• Zacks Equity Research
DaVita HealthCare (DVA) Surpasses Q1 Earnings and Revenue Estimates
DaVita HealthCare (DVA) delivered earnings and revenue surprises of 21.43% and 2.01%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
DVAASTH
UnknownZacks Investment Research• Zacks Equity Research
Option Care (OPCH) Q1 Earnings and Revenues Surpass Estimates
Option Care (OPCH) delivered earnings and revenue surprises of 18.18% and 4.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
OPCHASTH
UnknownBenzinga• Benzinga Insights
Truist Securities Maintains Hold Rating for Astrana Health: Here's What You Need To Know
Truist Securities has decided to maintain its Hold rating of Astrana Health (NASDAQ:ASTH) and raise its price target from $41.00 to $44.00.
Shares of Astrana Health are trading down 1.44% over the last 24 hours, at $44.39 per share.
A move to $44.00 would account for a 0.88% decrease from the current share price.
About Astrana Health
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based ...Full story available on Benzinga.com
ASTHAnalyst Ratings
UnknownZacks Investment Research• Zacks Equity Research
Astrana Health Inc. (ASTH) Q4 Earnings and Revenues Top Estimates
Astrana Health Inc. (ASTH) delivered earnings and revenue surprises of 52.94% and 1.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
ASTHSHCR
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal
